Literature DB >> 2502706

Valproic acid induction of coma in rats: synergism with NH4+ and pentobarbital.

L Zieve1, C Lyftogt.   

Abstract

Dose-response curves for the incidence of coma after intraperitoneal injections of various doses of valproic acid (VP) and octanoic acid (OA) showed that, mole for mole, valproic acid was less toxic than octanoic acid. However, a simultaneous subcoma dose of pentobarbital (PB) enhanced the toxicity of VP more than that of OA. The dose-response curve for NH4Cl was affected by simultaneous subcoma doses of VP and OA but not by PB. VP enhanced the toxicity of the NH4+ by 52%; OA enhanced the toxicity by 12%. PB added significantly to the toxicity of VP and NH4+ when the three were given simultaneously. Doses of 0.7 mmol NH4+ and 0.5 mmol VP given separately had little or no encephalopathic effect, with blood ammonias of 250-1250 micrograms/dl. When given simultaneously they induced a deep coma and raised the blood ammonia threefold, to about 3600 micrograms/dl. Similar doses of OA and NH4+, induced a similar deep coma, but blood levels of ammonia were not as high. Simultaneous injections of 250 mg glucose did not alter the results. Thus VP toxicity is enhanced substantially by its synergistic interactions with PB and the NH4+.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502706     DOI: 10.1007/bf00999388

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  10 in total

1.  Synergism between ammonia and fatty acids in the production of coma: implications for hepatic coma.

Authors:  F J Zieve; L Zieve; W M Doizaki; R B Gilsdorf
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

2.  Early structural and functional changes in liver of rats treated with a single dose of valproic acid.

Authors:  A M Jezequel; P Bonazzi; G Novelli; C Venturini; F Orlandi
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

3.  Increase of valproate-induced hyperammonemia in normal subjects by carbohydrate intake.

Authors:  J M Warter; C Marescaux; G Chabrier; L Rumbach; G Micheletti; B Reitzer; E Hirsch; M Imler
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

4.  The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies.

Authors:  J W Kesterson; G R Granneman; J M Machinist
Journal:  Hepatology       Date:  1984 Nov-Dec       Impact factor: 17.425

5.  The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats.

Authors:  D M Turnbull; A J Bone; K Bartlett; P P Koundakjian; H S Sherratt
Journal:  Biochem Pharmacol       Date:  1983-06-15       Impact factor: 5.858

6.  Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats.

Authors:  L Rumbach; J M Warter; A Rendon; C Marescaux; G Micheletti; A Waksman
Journal:  J Neurol Sci       Date:  1983 Oct-Nov       Impact factor: 3.181

7.  Sodium valproate associated with phenobarbital: effects on ammonia metabolism in humans.

Authors:  J M Warter; C Marescaux; C Brandt; L Rumbach; G Micheletti; G Chabrier; M Imler; D Kurtz
Journal:  Epilepsia       Date:  1983-10       Impact factor: 5.864

8.  Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA.

Authors:  F X Coude; G Grimber; P Parvy; D Rabier; F Petit
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

9.  Valproate-induced hepatic injury: analyses of 23 fatal cases.

Authors:  H J Zimmerman; K G Ishak
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

10.  Sodium valproate-induced hyperammonemia in the rat: role of the kidney.

Authors:  J M Warter; M Imler; C Marescaux; G Chabrier; L Rumbach; G Micheletti; J Krieger
Journal:  Eur J Pharmacol       Date:  1983-02-18       Impact factor: 4.432

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.